Eutilex.Co.,Ltd (KOSDAQ: A263050)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
Eutilex.Co.,Ltd (KOSDAQ: A263050) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.14M.
trading between 650.00 and 3.20K.
Tweenvest scores Eutilex.Co.,Ltd across four factors: quality 30/100, value 42/100. Its strongest factor is value.
A263050 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.14M
- Revenue (TTM)
- $4.98M
- P/E
- —
- EPS
- -555.97
- Dividend yield
- —
- Beta (5Y)
- 0.79
- 52-week high
- ₩3,200.00
- 52-week low
- ₩650.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.83M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Original BioMedicals Co., Ltd.TPEX: 6483 | $24.50M | NT$11.90 | +3.93% |
| Ribomic Inc.TSE: 4591 | $24.36M | ¥68.00 | -4.23% |
| Polyrizon Ltd.NasdaqCM: PLRZ | $24.29M | $10.00 | +11.26% |
| Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH | $24.20M | $5.08 | -4.69% |
| ABVC BioPharma, Inc.NasdaqCM: ABVC | $23.80M | $0.92 | -8.21% |
| Xbrane Biopharma AB (publ)OM: XBRANE | $23.72M | Skr11.40 | -18.28% |
| GeneMatrix Inc.KOSDAQ: A109820 | $23.69M | ₩1,549.00 | -9.94% |
| Transgenic Group Inc.TSE: 2342 | $23.63M | ¥224.00 | -4.27% |
Figures last refreshed Oct 18, 2026.